Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)
Condition(s):Hypercortisolism; Diabetes Mellitus, Type 2Last Updated:February 26, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Hypercortisolism; Diabetes Mellitus, Type 2Last Updated:February 26, 2024Recruiting
Condition(s):Abortion in First TrimesterLast Updated:October 17, 2023Recruiting
Condition(s):Abortion, Second Trimester; PPROM; Rupture, Spontaneous; Fetal Demise; Fetal Death; Fetal Demise From Miscarriage; Fetal Death Before 22 Weeks With Retention of Dead Fetus; Pregnancy Loss; Pregnancy ComplicationsLast Updated:April 25, 2023Recruiting
Condition(s):MiscarriageLast Updated:September 6, 2023Recruiting
Condition(s):Major Depressive Disorder; Childhood TraumaLast Updated:March 31, 2022Recruiting
Condition(s):Labor, InducedLast Updated:September 6, 2023Recruiting
Condition(s):Adenomyosis; MifepristoneLast Updated:December 9, 2021Unknown status
Condition(s):Abortion, MissedLast Updated:November 17, 2021Unknown status
Condition(s):Medical AbortionLast Updated:July 25, 2023Terminated
Condition(s):Induced Vaginal DeliveryLast Updated:January 11, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.